$750,000 of HCA HEALTHCARE INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"HR 2191, Physician Led and Rural Access to Quality Care Act; S 1816, Improving Seniors' Timely Access to Care Act of 2025; S 46, Health Care Affordability Act of 2025; S 2355, Patients Deserve Price Tags Act; HR 9390, Prices on the Wall Act of 2026 HR 2191, Physician Led and Rural Access to Quality Care Act; S 1816, Improving Seniors' Timely Access to Care Act of 2025; S 46, Health Care Affordability Act of 2025; S 2355, Patients Deserve Price Tags Act; HR 9390, Prices on the Wall Act of 2026"
You can find more data on corporate lobbying on Quiver Quantitative.
HCA Congressional Stock Trading
Members of Congress have traded $HCA stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $HCA stock by members of Congress over the last 6 months:
- REPRESENTATIVE JARED MOSKOWITZ has traded it 2 times. They made 2 purchases worth up to $30,000 on 06/17 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
HCA Hedge Fund Activity
We have seen 558 institutional investors add shares of HCA stock to their portfolio, and 732 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 2,768,503 shares (-62.9%) from their portfolio in Q2 2026, for an estimated $1,079,411,634
- JPMORGAN CHASE & CO added 2,285,832 shares (+inf%) to their portfolio in Q2 2026, for an estimated $891,223,038
- CRAKE ASSET MANAGEMENT LLP added 1,151,792 shares (+inf%) to their portfolio in Q2 2026, for an estimated $449,072,182
- CAPITAL INTERNATIONAL INVESTORS removed 1,116,665 shares (-36.8%) from their portfolio in Q2 2026, for an estimated $435,376,516
- VIKING GLOBAL INVESTORS LP removed 1,075,133 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $419,183,605
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,063,288 shares (+inf%) to their portfolio in Q2 2026, for an estimated $414,565,358
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,021,073 shares (+50200.2%) to their portfolio in Q2 2026, for an estimated $398,106,151
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
HCA Price Targets
Multiple analysts have issued price targets for $HCA recently. We have seen 10 analysts offer price targets for $HCA in the last 6 months, with a median target of $515.0.
Here are some recent targets:
- Andrew Mok from Barclays set a target price of $427.0 on 07/08/2026
- Sarah James from Cantor Fitzgerald set a target price of $525.0 on 07/07/2026
- Ryan Langston from TD Cowen set a target price of $431.0 on 06/22/2026
- Lance Wilkes from Bernstein set a target price of $413.0 on 06/04/2026
- David Macdonald from Truist Securities set a target price of $535.0 on 04/27/2026
- Matthew Gillmor from Keybanc set a target price of $510.0 on 04/27/2026
- Michael Wiederhorn from Oppenheimer set a target price of $520.0 on 04/27/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
